US Stock MarketDetailed Quotes

KYMR Kymera Therapeutics

Watchlist
  • 47.780
  • +1.930+4.21%
Close Aug 23 16:00 ET
  • 47.780
  • 0.0000.00%
Post 19:18 ET
3.09BMarket Cap-19825P/E (TTM)

Kymera Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Aug 24, 2024

Based on 9 analysts giving stock ratings to Kymera Therapeutics in the past 3 months

Strong Buy

  • Buy

    77.78%

  • Hold

    22.22%

  • Sell

    0.00%

Price Target

Updated: Aug 24, 2024

The average Kymera Therapeutics stock price target is 50.14 with a max estimate of 60.00 and a min estimate of 36.00

Review Kymera Therapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Aug 24, 2024

Strong Buy

  • Buy

    77.78%

  • Hold

    22.22%

  • Sell

    0.00%

Price Target

Updated: Aug 24, 2024

Heat List
US
Overall
Symbol
Latest Price
% Chg